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Abstract
OBJECTIVES: Aortic valve replacement through conventional sternotomy still represents the gold-standard surgical approach for aortic
valve disease. However, given the increasing number of patients with comorbidities, strategies that can improve operative results are
always sought. Minimally invasive aortic valve surgery, although related to a steep learning curve, might be associated with improved post-
operative outcomes. The main aim of this study was to assess whether significant differences exist in terms of operative and early results
between a mini-sternotomy and a right mini-thoracotomy approach for isolated aortic valve replacement without sutureless technologies.
METHODS: This is an observational retrospective multicentre study from nine Italian cardiac centres that analyses prospectively collected
data of patients who underwent isolated minimally invasive aortic valve replacement between January 2010 and December 2014. Two
approaches are considered (mini-sternotomy and mini-thoracotomy) and compared in terms of operative and early outcomes.
RESULTS: After interrogation of the centralized database, a total of 1130 patients were retrieved (854mini-sternotomy and 276mini-thoracotomy).
Patients in the mini-sternotomy group had a higher risk profile. There was no difference in terms of early mortality; cardiopulmonary bypass
and cross-clamp time did not differ significantly between the groups; and a significantly higher number of reoperations for bleeding was
observed in the right mini-thoracotomy group.
CONCLUSIONS: Both mini-sternotomy and mini-thoracotomy could be performed safely, with low mortality and postoperative morbidity.
The mini-thoracotomy approach was associated with a significantly higher rate of reoperation for bleeding. Uptake among cardiac centres
was low. Sutureless technologies could potentially increase surgical volume by simplifying the mini-thoracotomy procedure.
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INTRODUCTION
Aortic valve disease is a relatively common disorder in the elderly [1].
Aortic valve replacement via standard median sternotomy represents
the gold-standard treatment for aortic disease and is related to excel-
lent short- and long-term outcomes [2]. However, strategies that can
improve surgical performance are always sought. Minimally invasive
aortic valve replacement (MIAVR) can be performed using the
following different approaches: right parasternal, upper and lower
mini-sternotomy (MS), V-shaped, Z-shaped, inverse-T, J-shaped,
reverse-C and reverse-L partial MS, transverse sternotomy and right
mini-thoracotomy [2]. These approaches might be associated with
reduced bleeding, pain, infection, length of postoperative stay and
improved patient satisfaction; also, some economic and survival
benefits have been reported for MIAVR compared with aortic valve
replacement via conventional sternotomy [3, 4].
The two most frequently used approaches for MIAVS are a
‘J-shaped’ upper mini-sternotomy with entry into the third or the
fourth right intercostal space (MS) and right anterior mini-
thoracotomy (RT), both of which have theoretical potential to be
associated with certain improved outcomes. However, the super-
iority of one technique over the other has not yet been established.†Joint first authors.
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The relatively recent introduction of a sutureless/fast-release valve
has been associated with improvement in certain outcomes, espe-
cially with the RT approach [5]; however, the adoption of such
technologies remains limited to a few centres. The primary aims of
this retrospective observational multicentre study were as follows:
(i) to analyse operative and early postoperative outcomes of
patients who underwent non-sutureless MIAVR in order to under-
stand whether (ii) there are any significant differences between the
MS and RT approach.
MATERIALS ANDMETHODS
Patients, data extraction, collection and
distribution
GVM Care&Research (http://www.gvmnet.it) is a private group
that runs, in partnership with the Italian National Health System,
nine medium-volume cardiac units scattered, from North to
South, in the Italian territory (Fig. 1) and performs 10% of the
Italian cardiac surgical workload. The aortic valve surgery minim-
ally invasive programme started about 2009, with different uptake
between centres (Fig. 1). Patients undergoing concomitant aortic
procedures, such as aortic root replacement, ascending aorta re-
placement, valve-preserving aortic root replacement and aortic
valve repair, were excluded. A limited number of sutureless valves
were implanted; therefore, they were not considered in this study.
Cardiac units are subjected to a centralized Clinical Governance
Unit (CGU) that reviews on a monthly basis the data collected from
each cardiac unit and uploaded in a centralized database. The
online centralized database became operative in January 2010. The
demographics and characteristics of clinical patients are presented
in Table 1.
Surgical techniques
All nine cardiac units adopted the surgical set-up described below.
The mini-sternotomy is performed in a J-shaped fashion, up to
the third/fourth intercostal space. Both arterial and venous cannula-
tion are carried out centrally through the main surgical site (ascend-
ing aorta and right atrium with a double-stage cannula). If difficult
exposure of the right atrium is encountered, venous drainage is
achieved with percutaneous venous cannulas, such as BioMedicus
multistages (Medtronic, Minneapolis, Minn), Quickdraw (Edwards
LifeSciences) or RAP (Sorin), advanced through the right femoral
vein into the right atrium. Accurate positioning is achieved using
the Seldinger technique under transoesophageal echocardiograph-
ic guidance.
The right anterior mini-thoracotomy is performed through a 5–7 cm
incision usually at the level of the second intercostal space, although
some surgeons prefer the third intercostal space. No rib resection is
performed. The choice between ascending aorta or femoral arterial
cannulation is left to the surgeon’s preference. Direct aortic cannu-
lation is normally performed using low-profile cannulas, such as the
Easyflow (Sorin, Sallugia, Italy). Venous drainage is achieved in the
fashion described for MS. A preoperative computed tomography
(CT) scan without contrast enhancement is obtained to evaluate the
Figure 1: Geographical distribution of GVM Care and Research cardiac units. In parentheses is shown the number of non-sutureless minimally invasive aortic valve
replacements performed since 2010 via mini-sternotomy (MS), right mini-thoracotomy (RT) and conventional sternotomy (ST). From North to South: SALH: Salus
Hospital, Reggio Emilia, Emilia Romagna; MPH: Maria Pia Hospital, Torino, Piemonte; ICLAS: Istituto Clinico Ligure Alta Specialita’, Rapallo, Liguria; VTH: Villa Torri,
Bologna, Emilia Romagna; MCH: Maria Cecilia Hospital, Cotignola, Emilia Romagna; MBH: Maria Beatrice Hospital, Florence, Toscana; ANTH: Anthea Hospita, Bari,
Puglia; LECH: Citta’ di Lecce, Lecce, Puglia; MEH: Villa Maria Eleonora, Palermo, Sicily.
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anatomical relationship between the intercostal spaces, sternum,
ascending aorta and aortic valve. Exclusion criteria for RT are con-
sidered for the following: completely retrosternal or relatively right
lateral position of the ascending aorta or a deep chest (distance
between the ascending aorta and the sternum 10 cm or more);
however, the choice of approach depends on the surgeon’s and
team’s experience.
In both approaches, after vacuum-assisted cardiopulmonary
bypass (CPB; −40 to −60 mmHg) is established, a left ventricular vent
is placed through the right superior pulmonary vein, and the patient
is cooled to 34°C. The ascending aorta is clamped with the Cygnet
cross-clamp (Novare Surgical Systems, Cupertino, CA, USA), and an-
terograde cardioplegic solution is given into the aortic root or select-
ively into the coronary ostia using warm blood cardioplegia or cold
crystalloid solution (Custodiol Koehler Chemie, Alsbach-Haenlein,
Germany). In all cases, the surgical field is flooded with carbon
dioxide at a flow of 0.5 l/min.
Study design, ethics and end points
The study included patients from January 2010, and the search
was concluded in December 2014. The study was approved by
our independent ethics committee, and patient informed consent
was waived.
The main end point of the study was early mortality. Secondary
end points were operative and relevant postoperative outcomes
that are recorded in our database, such as aortic cross-clamp
(XCT) and CPB time, incidence of postoperative atrial fibrillation
(AF), transfusion of packed red blood cells (yes or no), reoperation
for bleeding, stroke, wound infection, de novo dialysis, permanent
pacemaker implantation and intensive care unit and postoperative
length of stay. Data are presented in Tables 1 and 2.
Definitions
In-hospital mortality included all deaths within 30 days of operation
irrespective of where the death occurred and all deaths in hospital
after 30 days among patients who had not been discharged after
the index operation. Postoperative stroke was defined as any new
permanent major (type I) neurological deficit that occurred at any
time during the postoperative hospitalization and/or new findings
on CT or magnetic resonance imaging, persisting for more than
72 h. Diagnosis of stroke was also confirmed and documented
by a consultant neurologist. New-onset AF was defined by the






Age (years) 72.2 ± 11.4 72.2 ± 11.2 0.89
Sex (female) 396 (46.4) 115 (41.7) 0.17
BMI (kg/m2) 27.6 ± 4.5 27.0 ± 4.2 0.03
Hypertension 622 (72.9) 195 (70.6) 0.48
Diabetes 0.94
Diet 20 (2.3) 6 (2.1)
NIDDM 109 (12.8) 32 (11.6)
IDDM 27 (3.2) 10 (3.6)
NYHA III–IV 449 (52.6) 93 (33.7) 0.001
CCS 4 2 (0.2) 0 0.93
Recent MI 2 (0.2) 0 0.66
COPD 88 (10.3) 27 (9.8) 0.80
Preoperative AF 70 (0.9) 20 (7.2) 0.61
EuroSCORE (mean ± SD) 6.4 ± 2.5 6.1 ± 2.3 0.03
Prevalent aetiologya
AS 601 (70.4) 200 (72.5) 0.99
AR 103 (11.7) 27(9.8) 0.30
Mixed disease 147 (17.2) 49 (17.8) 0.99
XCT (min; mean ± SD) 62.4 ± 23.7 62.6 ± 24.8 0.11
CPB time (min; mean ± SD) 76.8 ± 31.7 78.7 ± 31.7 0.64
Valve type
Mechanical 109 (12.8) 21 (7.6)
Tissue 745 (87.2) 255 (92.4)
Valve sizeb
19 29 (3.4) 1 0.001
21 204 (23.9) 55 (19.9) 0.45
23 398 (46.6) 93 (33.7) 0.001
25 171 (20) 89 (32.2) 0.94
27 20 (2.3) 27 (9.8) 0.001
29 13 (1.5) 0 0.001
AF: atrial fibrillation; AR: aortic regurgitation; AS: aortic stenosis. BMI: body mass index; CCS: Canadian Class Score; COPD: chronic obstructive pulmonary
disease; CPB: cardiopulmonary bypass; MI: myocardial infarction; (N)IDDM: (non)-insulin-dependent diabetes mellitus; NYHA: New York Heart Association;
XCT: cross-clamping time.
aThree missing data.
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documentation of AF of any duration at any point in the post-
operative period on a rhythm strip or 12-lead ECG. Renal compli-
cations were defined as the requirement for haemodialysis.
Respiratory failure was defined as the need for re-intubation.
Wound dehiscence was defined as deep MS or RT wound infec-
tion necessitating surgical intervention or vacuum assisted closure
therapy. Blood transfusion was indicated if patients received
packed red cells.
Statistical analysis
Patients’ data were summarized as the mean ± standard deviation
or median and interquartile range for asymmetrically distributed
continuous variables. Categorical data were expressed as percen-
tages or prevalence, as appropriate. The Shapiro–Wilk test was used
to check for the normality of data in groups before further analysis.
Continuous normally or non-normally distributed variables were
compared between two groups using Student’s unpaired t-test or
the Mann–Whitney U-test, respectively; the latter test was also used
to compare ordinal variables. The frequency ratios between two
groups were compared using the χ2 test. Values of P < 0.05 were
considered statistically significant. Statistical analysis was performed
using the Statistical Package for Social Sciences software (SPSS)
version 22.0 for Windows (IBM Corporation, Armonk, NY, USA).
RESULTS
Baseline characteristics
After interrogation of the database, a total of 2962 patients were
retrieved, of whom 854 underwent MS and 276 RT. Figure 1
shows the total volume and distribution of approaches in each
centre. The baseline characteristics, burden of disease and type of
valve implanted for the two groups are listed in Table 1. Patients
in the MS group had a higher body mass index (P = 0.03), were
more symptomatic (P = 0.001) and had a higher operative risk
profile (P = 0.03).
Primary end point: early mortality
Early mortality was similar in both groups (MS n = 18, 3.3% vs RT
n = 3, 1.1%, P = 0.28; Table 2).
Secondary end point: operative outcomes
The XCT and CPB time were similar in both groups (XCT:
MS = 62.4 ± 23.7 vs RT = 62.6 ± 24.8 min, P = 0.11; CPB time:
MS = 76.8 ± 31.7 vs RT = 78.7 ± 31.7 min, P = 0.64; Table 1).
Secondary end point: early postoperative
outcomes
Early postoperative outcomes are reported in Table 2. A higher in-
cidence of re-exploration for bleeding was observed in the RT
group (P = 0.006).
DISCUSSION
Surgical aortic valve replacement, a well-established and safe
technique, remains the gold-standard treatment for severe symp-
tomatic aortic valve diseases [6]. However, the population is
ageing, and a consistent number of patients with severe aortic
stenosis are denied the surgical procedure owing to high surgical
risk for multiple comorbidities [7]; therefore, strategies that can
improve results are welcome. Minimally invasive aortic valve re-
placement is generally performed through an MS or RT approach
[2], both of which might be related to certain better postoperative
outcomes than standard sternotomy [8–10]. To date, there are dif-
ferent reports in the literature comparing sternotomy vs MS or RT,
but there is a lack of understanding of whether there are signifi-
cant differences between these two approaches [11]. A recent
Bayesian meta-analysis comparing the two approaches showed
that RT may be associated with longer CPB and cross-clamp dura-
tions, but has similar postoperative outcomes compared with MS
[11].Miceli et al. [5] reported that the RT approach was significantly






Blood transfusion 324 (41.2) 106 (40.6) 0.87
Reoperation for bleeding 30 (3.8) 21 (8.0) 0.006
Postoperative AF 223 (32.8) 85 (32.2) 0.29
Stroke 3 (0.4) 0 0.32
Wound dehiscence 18 (3.1) 9 (3.3) 0.29
Permanent pacemaker 10 (1.3) 7 (2.7) 0.12
De novo dialysis 4 (0.5) 2 (0.8) 0.63
Re-intubation 16 (2.0) 11 (4.2) 0.05
ICU length of stay 2.5 ± 4.0 2.4 ± 4.1 0.07
In-hospital length of stay 11.4 ± 9.4 11.5 ± 11.5 0.91
Early mortality 18 (3.3) 3 (1.1) 0.28
AF: atrial fibrillation; ICU: intensive care unit.
Early mortality was defined as in-hospital mortality and all deaths within 30 days of operation irrespective of where the death occurred.
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associated with improved postoperative outcomes compared with
the MS approach; however, sutureless technologies were used in
the series. In fact, recent reports have described a positive impact
of sutureless and rapid-deployment aortic valve replacement on
immediate postoperative outcomes [12], especially when MIAVRs
were performed [13–16]; however, robust evidence is lacking on
the long-term outcomes [17].
We have already demonstrated the feasibility and safety of non-
sutureless MIAVR performed through the RT approach [18].
In this study, we wanted to carry out a retrospective comparison
of the early operative and postoperative results of patients who
underwent non-sutureless MIAVR, both MS and RT, among the
nine Italian cardiac units of the entire GVM Care and Research
group in order to investigate safety in terms of mortality and mor-
bidity and to ascertain whether differences exist between these
two surgical approaches. The analysis of 1130 patients showed
that only reoperation for bleeding was significantly higher in the
RT group, although the highest incidence was observed during the
first period of the learning curve in some cases; moreover, that
was in relationship to chest wall bleeding [18]. Both of the
approaches were also associated with limited postoperative com-
plications, similar to sutureless or fast-release series reported in
the literature [15–17]. However, this finding should be set in the
context of the reduced RT group risk profile, whereby there was a
propensity to select ‘easier’ patients for the RT approach, with
lower body mass index, fewer symptoms and lower EuroSCORE.
Although MIAVR is more technically demanding, our recorded
surgical times for both MS and RT were lower than those reported
in the last STS database in the full sternotomy stented group
(mean XCT 78 min, mean CPB time 106 min) [19]. In our series,
there were no differences in terms of CPB time and XCT between
the MS and RT group; this was attributable to the running sutures
surgical implantation technique used in the two centres account-
ing for the largest number of RT approaches (Fig. 1). In the RT
series, however, a lower incidence of small annulus was found
(Table 1).
An important finding is that the general uptake of MIAVR in
centres was low, with only one cardiac unit accounting for a
medium volume of both approaches, but with a preference for
the MS approach (Fig. 1). This might well be related to the greater
technical complexity of the RT approach as a result of its less con-
ventional access. Another finding is that the incidence of wound
infection was relatively high (>3% in both groups), which may
be seen in relationship to the learning curve and/or to groin
dehiscence.
Notably, the median length of stay was 11 days, but after min-
imally invasive surgery the patients were usually discharged home
rather than being referred to rehabilitation centres.
A strength of this study is that it reports real-world data from a
real-world population and merges a relatively large number of
patients. Results from different centres and different surgeons in
diverse phases of the training for minimally invasive surgery are
reported in a single scenario.
This study has several limitations. Firstly, this is a retrospectively
observational study, with all the limitations that may entail;
however, data were collected prospectively. Secondly, surgeon-
related skills and preferences might have affected the results;
some surgeons preferred RT and others MS. Although MS could
theoretically have been performed in all cases, the RT approach
was dependent upon the anatomical position of the ascending
aorta and, ultimately, upon surgeon preferences. That resulted in a
bias of selection; in fact, the RT group accounted for a lower risk
profile. Moreover, there were different set-ups, specifically with
regard to RT in terms of the cannulation site. However, the inci-
dence of stroke was low in both groups, indicating that antero-
grade or retrograde perfusion had no impact on neurological
events. Preoperative left ventricular function and pulmonary
hypertension were not retrieved form the aortic database because
the completeness of the echocardiographic database was <80%;
therefore, they could not be incorporated into the binary logistic
regression model. This study remains confined to the early out-
comes; no long-term events were considered in the analysis and
no quality-of-life-related issues or cost-effectiveness analysis/re-
habilitation resources. Also, this was not an intention-to-treat ana-
lysis, hence the number of patients converted to a full sternotomy
could not be reported. A prospective analysis comparing the two
approaches would be of interest, with an arm including sutureless
and fast-release valves. Lastly, no comparison with conventional
sternotomy was made and no propensity score analysis could be
performed given the limited number of patients in the RT group.
In conclusion, in this retrospective observational multicentre
study both MS and RT were safe approaches for isolated non-
sutureless aortic valve replacement, with low mortality and favour-
able intraoperative and early postoperative outcomes, similar to
certain sutureless series reported in literature [15–17]. However,
the RT approach was associated with a significantly higher inci-
dence of reoperation for bleeding. The volume of MIAVR among
centres was low, with a larger number of MS approaches per-
formed. Potentially, the use of sutureless technologies with ad-
equate training may increase the adoption of minimally invasive
approaches, but that requires further investigation.
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